Valuation (21%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -1.03 | 35.44 |
| PEG Ratio (TTM) | -0.06 | -2.74 |
| P/S Ratio (TTM) | 2.11 | 6.39 |
| P/B Ratio (TTM) | 0.49 | 5.95 |
| P/FCF Ratio (TTM) | -1.18 | 45.33 |
| Price to 5YR AVG Earnings Ratio | N/A | 62.55 |
| Price to 5YR AVG FCF Ratio | N/A | 34.45 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -44.65% | 5.33% |
| ROE (TTM) | -42.56% | 26.24% |
| Net Profit Margin (TTM) | -203.71% | 0.94% |
| ROIC 5YR AVG | N/A | 4.32% |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 8.66% | -149.77% | N/A |
| Revenue | -15.20% | -2.85% | N/A |
| Net Income | -6.85% | -21.02% | N/A |
| Cash Flow | -2.69% | -37.49% | N/A |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 13.88 | 2.59 |
| Quick Ratio (TTM) | 12.70 | 1.96 |
| D/E Ratio (TTM) | 0.01 | -0.04 |
| Interest Coverage (TTM) | -63.89 | 13.08 |
| Piotroski F-Score | 2 | 6 |
| Altman Z-Score | N/A | 7.11 |
| LTL to 5YR AVG FCF | N/A | 3.62 |
| Shares Outstanding Growth 5YR AVG | N/A | 2.25% |